Oren J. Becher, MD | Authors

DAVES PHARMACY 1

Articles

Pediatric Neuro-Oncology: Time to Go Molecular

May 15, 2016

One recurring theme from genomic studies of pediatric CNS tumors (and almost all cancers, for that matter) is that tumors that historically appeared to be a single entity based on examination under the microscope and routine immunohistochemical staining actually harbor molecularly distinct subgroups when analyzed by genomic sequencing techniques.